Recommended

New webinar with Fujifilm: Monocyte activation test (MAT): Insight into examining regulations and markets prospects
New webinar: The path to optimisation in pharmaceutical microbiology
Join our webinar: An alternative medium to support sterility testing using the Growth Direct® Rapid Sterility System
Discover more in our new application note: validating recombinant cascade reagents in 3 simple steps
webinar

The path forward — Altasciences’ approach to project management

Discover the opportunities Altasciences’ hybrid approach to project management can offer your drug development programme.

About this on-demand webinar

Altasciences offers a unique approach that can lower your costs and reduce programme timelines from lead candidate selection to clinical proof-of-concept by up to 40 percent.

A significant piece of this offering is the development and implementation of project and programme management. By working in close collaboration with key internal and external stakeholders, project and programme managers ensure seamless and timely communications with sponsors and synchronised workflows between departments and sites.

This webinar will focus on the opportunities our hybrid approach can offer your drug development program.

Learning outcomes

  • The difference between project and programme management
  • How Altasciences’ programme management approach is unique
  • The benefits of involving project management in IND- and NDA-enabling packages of non-clinical studies, including specific case studies
  • Altasciences’ commitment to Tell Us OnceTM, including real-life experiences and feedback from our clients

Our speakers

Lauren SzczurowskiLauren Szczurowski, Vice President, Scientific Project Management, Altasciences

Lauren Szczurowski, Vice President, Scientific Project Management, joined Altasciences in 2017 and has approximately 20 years of clinical trial management experience, including 10 years in departmental leadership and strategic growth. She began her career in early development managing Phase I/IIb multi-centre studies in healthy volunteers and patient populations, with a focus on CNS and infectious diseases. Prior to joining Altasciences, she was responsible for a team of clinical trial managers, overseeing more than 30 multi-centre global oncology trials ranging from Phase I to Phase III. A strategic and tactical leader, Lauren plays a significant role in driving Altasciences’ growth by managing team and system integrations and successful collaborations across the organisation.

melanie barthMelanie Barth, Associate Director, Scientific Project Management, Altasciences

Melanie Barth, Associate Director, Scientific Project Management, has worked in early phase clinical research for over 20 years. She joined Altasciences in 2014 as Associate Director, Clinical Operations and subsequently moved over to the project management team in 2018.  Melanie has experience working on pre-clinical and clinical Phase I and IV studies. Her vast experience enables her to support a team of project managers and co-ordinators, using her problem-solving skills to execute projects efficiently and within budget. Melanie’s areas of expertise include training, site management, oversight of data services (data management, biostatistics, programming, clinical monitoring, and medical writing), and close collaboration with vendors.